About the Centre
The MRC-funded Centre for Drug Safety Science was established by the University of Liverpool in 2009 to bring together a critical mass of knowledge and technologies in order to advance our understanding of Adverse Drug Reactions (ADRs). The Centre has recently had funding extended by the MRC up to 2019 and aims to make significant progress over the next five years.
Find out more about our work by following the team as they process a blood sample in this video:
To create a world-leading centre for the investigation of fundamental mechanisms of clinically important adverse drug reactions with the overall aim of preventing such reactions by improved drug selection, drug design and more informed patient selection.
To improve Drug Safety Science by investigating adverse drug reactions from man to molecule, and back again. By "closing the loop" on the mechanisms of adverse drug reactions it will be possible to:
- Inform the medicinal chemist with respect to drug design at an early stage in development
- Advise the doctor and patient on safe drug selection
- Advise regulation and industry
- Improve the training of scientists, clinicians and regulators in Drug Safety Science
- Improve communication in Drug Safety Science in order to inform the public about the balance between potential risks and benefit of any medicine.